AVANIR Pharmaceuticals Invites Investors to Its Second Fiscal Quarter 2005 Conference Call on May 16, 2005

AVANIR Pharmaceuticals (AMEX:AVN) will webcast its
quarterly conference call on Monday, May 16, 2005 at 1:30 p.m.
Pacific/ 4:30 p.m. Eastern. The call will be webcast live through
AVANIR's corporate website at http://www.avanir.com/ and will feature
Dr. Gerald Yakatan, President and Chief Executive Officer, and Gregory
P. Hanson, Vice President and Chief Financial Officer. A press release
announcing the quarter's financial results will be released at market
close the same day.
   It is recommended that you go to AVANIR's website at least 10
minutes in advance of the webcast to download any applicable software.
For those who cannot listen to the live broadcast, the online replay
will be available for 90 days, and a phone replay will be available
through May 23, 2005, by dialing 888-266-2081 (domestic) and 703-925-
2533 (international) and entering the passcode 703112.
   AVANIR Pharmaceuticals is a drug discovery and development company
focused on developing and commercializing novel therapeutic products
for the treatment of chronic diseases. Our product candidates address
therapeutic markets that include central nervous system and
cardiovascular disorders, inflammation, and infectious disease. The
Company's first commercialized product, Abreva(R), is marketed in
North America by GlaxoSmithKline Consumer Healthcare and is the
leading over-the-counter product for the treatment of cold sores.
Further information about AVANIR can be found at www.avanir.com.